Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
Dren Investigational Site, Denver, Colorado Dren Investigational Site, Orlando, Florida Dren Investigational Site, Sarasota, Florida Dren Investigational Site, Huntersville, North Carolina Dren Investigational Site, Oklahoma City, Oklahoma Dren Investigational Site, Greenville, South Carolina Dren Investigational Site, Austin, Texas Dren Investigational Site, Dallas, Texas Dren Investigational Site, San Antonio, Texas Dren Investigational Site, Fairfax, Virginia